Financial statements Laboratorium Farmaceutyczne Labofarm
Balance sheet data of LABORATORIUM FARMACEUTYCZNE LABOFARM
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 822 475,46 | 969 149,71 | 930 184,50 | 775 883,35 | 613 211,96 |
| A. Fixed assets | 3 089,48 | 1 614,44 | 1 000,00 | 1 000,00 | 1 000,00 |
| B. Current assets | 819 385,98 | 967 535,27 | 929 184,50 | 774 883,35 | 612 211,96 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 822 475,46 | 969 149,71 | 930 184,50 | 775 883,35 | 613 211,96 |
| A. Equity | 769 352,41 | 842 206,21 | 870 177,46 | 733 524,40 | 569 509,45 |
| B. Liabilities and provisions for liabilities | 53 123,05 | 126 943,50 | 60 007,04 | 42 358,95 | 43 702,51 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.